Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Viral infections and antiphospholipid antibodies

Uthman, I. W., & Gharavi, A. E. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.28303 · Cited by 302

Mechanisms of Stroke in COVID-19

Spence, J. D., de Freitas, G. R., Pettigrew, L. C., Ay, H., Liebeskind, D. S., Kase, C. S., Brutto, Ó. H. D., Hankey, G. J., & Venketasubramanian, N. (2020) · Cerebrovascular Diseases · doi:10.1159/000509581 · Cited by 248

Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review

Alijotas‐Reig, J., Esteve‐Valverde, E., Belizna, C. C., Selva-O’Callaghan, A., Pardos‐Gea, J., Quintana, Á., MEKINIAN, A., Anunciación-Llunell, A., & Miró‐Mur, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102569 · Cited by 239

Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians

Maury, A., Lyoubi, A., Peiffer‐Smadja, N., de Broucker, T., & Meppiel, E. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.10.001 · Cited by 241

Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries

Freeman, E. E., McMahon, D. E., Lipoff, J. B., Rosenbach, M. A., Kovarik, C., Takeshita, J., French, L. E., THIERS, B. H., Hruza, G. J., & Fox, L. P. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.05.109 · Cited by 232

Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights

Divani, A. A., Andalib, S., Napoli, M. D., Lattanzi, S., Hussain, M. S., Biller, J., McCullough, L. D., Azarpazhooh, M. R., Seletska, A., Mayer, S. A., et al. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104941 · Cited by 236

Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation

Vaid, A., Somani, S. S., Russak, A. J., Freitas, J. K. D., Chaudhry, F. F., Paranjpe, I., Johnson, K. W., Lee, S. J., Miotto, R., Zhao, S., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/24018 · Cited by 238

Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications

Merrill, J. T., Erkan, D., Winakur, J., & James, J. A. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0474-5 · Cited by 234

Cardiovascular Manifestations of COVID-19 Infection

Magadum, A., & Kishore, R. (2020) · Cells · doi:10.3390/cells9112508 · Cited by 230

Dysregulated naive B cells and de novo autoreactivity in severe COVID-19

Woodruff, M. C., Ramonell, R. P., Haddad, N. S., Anam, F. A., Rudolph, M. E., Walker, T. A., Truong, A. D., Dixit, A. N., Han, J. E., Cabrera-Mora, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05273-0 · Cited by 226

Coagulation and anticoagulation in COVID-19

Hadid, T. H., Kafri, Z., & Al-Katib, A. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100761 · Cited by 229

Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression

Schönrich, G., Raftery, M. J., & Samstag, Y. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100741 · Cited by 226

Association among income loss, financial strain and depressive symptoms during COVID-19: Evidence from two longitudinal studies

Hertz‐Palmor, N., Moore, T. M., Gothelf, D., DiDomenico, G. E., Dekel, I., Greenberg, D. M., Brown, L. A., Matalon, N., Visoki, E., White, L. K., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.04.054 · Cited by 226

Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?

Panigrahy, D., Gilligan, M. M., Huang, S., Gartung, A., Cortés‐Puch, I., Sime, P. J., Phipps, R. P., Serhan, C. N., & Hammock, B. D. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09889-4 · Cited by 222

Liver Biochemistries in Hospitalized Patients With COVID‐19

Bloom, P. P., Meyerowitz, E. A., Reinus, Z., Daidone, M., Gustafson, J. L., Kim, A. Y., Schaefer, E. A. K., & Chung, R. T. (2020) · Hepatology · doi:10.1002/hep.31326 · Cited by 216

SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart

Dhakal, B. P., Sweitzer, N. K., Indik, J. H., Acharya, D., & William, P. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.05.101 · Cited by 216

Gastrointestinal Complications in Critically Ill Patients With COVID-19

Kaafarani, H. M. A., El Moheb, M., Hwabejire, J. O., Naar, L., Christensen, M. A., Breen, K., Gaitanidis, A., Alser, O., Mashbari, H., Bankhead-Kendall, B., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004004 · Cited by 211

Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions

Favas, T. T., Dev, P., Chaurasia, R. N., Chakravarty, K., Mishra, R., Joshi, D., Mishra, V. N., Kumar, A., Singh, V. K., Pandey, M., et al. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04801-y · Cited by 218

COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy

Perricone, C., Bartoloni, E., Bursi, R., Cafaro, G., Guidelli, G. M., Shoenfeld, Y., & Gerli, R. (2020) · Immunologic Research · doi:10.1007/s12026-020-09145-5 · Cited by 238

Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak

Fernández‐Nieto, D., ­Jimenez‐Cauhe, J., Suárez‐Valle, A., Moreno‐Arrones, Ó. M., Saceda‐Corralo, D., Arana-Raja, A., & Ortega-Quijano, D. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.04.093 · Cited by 204

Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system

Lazzaroni, M. G., Piantoni, S., Masneri, S., Garrafa, E., Martini, G., Tincani, A., Andréoli, L., & Franceschini, F. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100745 · Cited by 204

Neurological manifestations of COVID-19: a systematic review

Nepal, G., Rehrig, J. H., Shrestha, G. S., Shing, Y. K., Yadav, J. K., Ojha, R., Pokhrel, G., Tu, Z., & Huang, D. (2020) · Critical Care · doi:10.1186/s13054-020-03121-z · Cited by 201

Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis

Collantes, M. E., Espiritu, A. I., Sy, M. C. C., Anlacan, V. M. M., & Jamora, R. D. G. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.146 · Cited by 206

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

Smadja, D. M., Mentzer, S. J., Fontenay, M., Laffan, M., Ackermann, M., Helms, J., Jonigk, D. D., Chocron, R., Pier, G. B., Gendron, N., et al. (2021) · Angiogenesis · doi:10.1007/s10456-021-09805-6 · Cited by 204

Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID‐19 pandemic, now and in the future

Mok, V., Pendlebury, S. T., Wong, A., Alladi, S., Au, L. W. C., Bath, P. M., Biessels, G. J., Chen, C., Cordonnier, C., Dichgans, M., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12143 · Cited by 206

Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis and Myelitis in COVID-19

Zhou, S., Jones‐López, E. C., Soneji, D. J., Azevedo, C. J., & Patel, V. R. (2020) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001049 · Cited by 197

Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?

Edeas, M., Saleh, J., & Peyssonnaux, C. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.110 · Cited by 194

Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome

Borghi, M. O., Beltagy, A., Garrafa, E., Curreli, D., Cecchini, G., Bodio, C., Grossi, C., Blengino, S., Tincani, A., Franceschini, F., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584241 · Cited by 193

Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome

Knight, J. S., & Kanthi, Y. M. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00916-w · Cited by 209

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients

Guilmot, A., Slootjes, S. M., Sellimi, A., Bronchain, M., Hanseeuw, B. J., Belkhir, L., Yombi, J. C., Greef, J. D., Pothen, L., Yıldız, H., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10108-x · Cited by 194

Peripheral Nervous System Manifestations Associated with COVID-19

Andalib, S., Biller, J., Napoli, M. D., Moghimi, N., McCullough, L. D., Rubiños, C., Nobleza, C. O., Azarpazhooh, M. R., Catanese, L., Elicer, I., et al. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01102-5 · Cited by 198

The pulmonary pathology of COVID-19

Bösmüller, H., Matter, M., Fend, F., & Tzankov, A. (2021) · Virchows Archiv · doi:10.1007/s00428-021-03053-1 · Cited by 180

Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth

Sentilhes, L., Marcillac, F. D., Jouffrieau, C., Kuhn, P., Thuet, V., Hansmann, Y., Ruch, Y., Fafi‐Kremer, S., & Deruelle, P. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.06.022 · Cited by 190

Covid‐19 and dengue: Double punches for dengue‐endemic countries in Asia

Harapan, H., Ryan, M., Yohan, B., Abidin, R. S., Nainu, F., Rakib, A., Jahan, I., Emran, T. B., Ullah, I., Panta, K., et al. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2161 · Cited by 188

COVID‐19 and Immunological Dysregulation: Can Autoantibodies be Useful?

Pascolini, S., Vannini, A., Deleonardi, G., Ciordinik, M., Sensoli, A., Carletti, I., Veronesi, L., Ricci, C., Pronesti, A., Mazzanti, L., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12908 · Cited by 188

Heparin Resistance — Clinical Perspectives and Management Strategies

Levy, J. H., & Connors, J. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2104091 · Cited by 188

Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?

Devreese, K. M. J., Linskens, E. A., Benoît, D., & Peperstraete, H. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14994 · Cited by 190

Impact of the COVID-19 pandemic on publication dynamics and non-COVID-19 research production

Raynaud, M., Goutaudier, V., Louis, K., Awadhi, S. A., Dubourg, Q., Truchot, A., Brousse, R., Saleh, N., Giarraputo, A., Debiais, C., et al. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01404-9 · Cited by 202

Selenium and selenoproteins in viral infection with potential relevance to COVID-19

Zhang, J., Saad, R., Taylor, E. W., & Rayman, M. P. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101715 · Cited by 191

Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases

Horowitz, R. I., Freeman, P. R., & Bruzzese, J. (2020) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2020.101063 · Cited by 184

Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study

Xie, Y., Bowe, B. C., Maddukuri, G. S., & Al‐Aly, Z. (2020) · BMJ · doi:10.1136/bmj.m4677 · Cited by 182

Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily

Gavriilaki, E., & Brodsky, R. A. (2020) · British Journal of Haematology · doi:10.1111/bjh.16783 · Cited by 178

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy

Moll, G., Drzeniek, N. M., Kamhieh‐Milz, J., Geißler, S., Volk, H., & Reinke, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01091 · Cited by 176

The association between treatment with heparin and survival in patients with Covid-19

Ayerbe, L., Risco-Risco, C., & Ayis, S. A. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02162-z · Cited by 176

Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology

Cleary, S. J., Pitchford, S. C., Amison, R. T., Carrington, R., Cabrera, C. L. R., Magnen, M., Looney, M. R., Gray, E., & Page, C. P. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15143 · Cited by 169

Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

Xiao, M., Zhang, Y., Zhang, S., Qin, X., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41425 · Cited by 174

Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors

Kaseda, E. T., & Levine, A. J. (2020) · The Clinical Neuropsychologist · doi:10.1080/13854046.2020.1811894 · Cited by 181

Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples

Leng, L., Cao, R., Ma, J., Mou, D., Zhu, Y., Li, W., Lv, L., Gao, D., Zhang, S., Gong, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00355-9 · Cited by 168

Acute Cerebrovascular Events in Hospitalized COVID-19 Patients

Rothstein, A., Oldridge, O., Schwennesen, H. T., Do, D., & Cucchiara, B. L. (2020) · Stroke · doi:10.1161/strokeaha.120.030995 · Cited by 172

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

Gerotziafas, G., Catalano, M., Colgan, M. P., Pécsvárady, Z., Wautrecht, J. C., Fazeli, B., Olinic, D.-M., Farkas, K., Elalamy, I., Falanga, A., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1715798 · Cited by 171

The journey of remdesivir: from Ebola to COVID-19

Pardo, J., Shukla, A. M., Chamarthi, G., & Gupte, A. A. (2020) · Drugs in Context · doi:10.7573/dic.2020-4-14 · Cited by 168

Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19

Escalard, S., Maïer, B., Redjem, H., Delvoye, F., Hébert, S., Smajda, S., Cicciò, G., Désilles, J., Mazighi, M., Blanc, R., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.030574 · Cited by 168

SARS‐CoV‐2 infection as a trigger of autoimmune response

Sacchi, M. C., Tamiazzo, S., Stobbione, P., Agatea, L., Gaspari, P. D., Stecca, A., Lauritano, E. C., Roveta, A., Tozzoli, R., Guaschino, R., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12953 · Cited by 165

Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection

McGonagle, D., Marco, G. D., & Bridgewood, C. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102662 · Cited by 169

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Zhang, Y., Cao, W., Jiang, W., Xiao, M., Li, Y., Tang, N., Liu, Z., Yan, X., Zhao, Y., Li, T., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02182-9 · Cited by 162

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

Gawalko, M. M., Kapłon‐Cieślicka, A., Hohl, M., Dobrev, D., & Linz, D. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100631 · Cited by 162

Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration

Chen, R., Lan, Z., Ye, J., Pang, L., Liu, Y., Wu, W., Qin, X., Guo, Y., & Zhang, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.589095 · Cited by 165

Neuropathobiology of COVID-19: The Role for Glia

Tremblay, M.-E., Madore, C., Bordeleau, M., Tian, L., & Verkhratsky, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592214 · Cited by 159

Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression

Beltrán-García, J., Osca-Verdegal, R., Pallardó, F. V., Ferreres, J., Rodríguez, M. D. P., Mulet, S., Sanchis‐Gomar, F., Carbonell, N., & García‐Giménez, J. L. (2020) · Antioxidants · doi:10.3390/antiox9100936 · Cited by 162

Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers

Rello, J., Storti, E., Belliato, M., & Serrano, R. (2020) · European Respiratory Journal · doi:10.1183/13993003.01028-2020 · Cited by 158

Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses

Gavriilaki, E., Anyfanti, P., Gavriilaki, M., Lazaridis, A. A., Δούμα, Σ., & Gkaliagkousi, Ε. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01078-6 · Cited by 160

How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms

Nikbakht, F., Mohammadkhanizadeh, A., & Mohammadi, E. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102535 · Cited by 159

Immune responses during COVID-19 infection

Melenotte, C., Silvin, A., Goubet, A., Lahmar, I., Dubuisson, A., Zumla, A. I., Raoult, D., Merad-Boudia, M., Gachot, B., Henon, C., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1807836 · Cited by 167

Encephalitis Associated with COVID-19 Infection in an 11-Year-Old Child

McAbee, G. N., Brosgol, Y., Pavlakis, S. G., Agha, R., & Gaffoor, M. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.04.013 · Cited by 153

Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye

Bertoli, F., Veritti, D., Danese, C., Samassa, F., Sarao, V., Rassu, N., Gambato, T., & Lanzetta, P. (2020) · Journal of Ophthalmology · doi:10.1155/2020/4827304 · Cited by 155

Natural history of COVID-19 and therapeutic options

Gautret, P., Million, M., Jarrot, P., Camoin‐Jau, L., Colson, P., Fenollar, F., Léone, M., Scola, B. L., Devaux, C. A., Gaubert, J. Y., et al. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1847640 · Cited by 158

Effect of COVID-19 on the Organs

Jain, U. (2020) · Cureus · doi:10.7759/cureus.9540 · Cited by 165

COVID-19 and Hypercoagulability: A Review

Kichloo, A., Dettloff, K., Aljadah, M. M., Albosta, M. S., Jamal, S. M., Singh, J., Wani, F., Kumar, A., Vallabhaneni, S., & Khan, M. Z. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620962853 · Cited by 154

Pulmonary Vascular Manifestations of COVID-19 Pneumonia

Lang, M., Som, A., Carey, D. E., Reid, N., Mendoza, D. P., Flores, E. J., Li, M., Shepard, J.-A. O., & Little, B. P. (2020) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.2020200277 · Cited by 147

Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring

Susen, S., Tacquard, C. A., Mansour, A., Mansour, A., Garrigue, D., Nguyên, P., Godiér, A., Testa, S., Levy, J. H., Albaladejo, P., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03000-7 · Cited by 150

COVID ‐19: immunopathology, pathophysiological mechanisms, and treatment options

van Eijk, L. E., Binkhorst, M., Bourgonje, A. R., Offringa, A. K., Mulder, D. J., Bos, E. M., Kolundžić, N., Abdulle, A. E., van der Voort, P. H. J., Rikkert, M. G. M. O., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5642 · Cited by 156

Elevated d-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019

Shah, S., Shah, K. B., Patel, S., Patel, F. S., Osman, M., Velagapudi, P., Turagam, M. K., Lakkireddy, D., & Garg, J. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000330 · Cited by 149

Neurological complications in patients with SARS-CoV-2 infection: a systematic review

Munhoz, R. P., Pedroso, J. L., Nascimento, F. A., de Almeida, S. M., Barsottini, O. G. P., Cardoso, F., & Teive, H. A. G. (2020) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20200051 · Cited by 177

Retrospective cohort study of clinical characteristics of 2199 hospitalised patients with COVID-19 in New York City

Paranjpe, I., Russak, A. J., Freitas, J. K. D., Lala, A., Miotto, R., Vaid, A., Johnson, K. W., Danieletto, M., Golden, E., Meyer, D., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040736 · Cited by 155

Thrombotic microangiopathy in a patient with COVID-19

Jhaveri, K. D., Meir, L. R., Chang, B. S. F., Parikh, R., Wanchoo, R., Barilla-LaBarca, M.-L., Bijol, V., & Hajizadeh, N. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.025 · Cited by 144

Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine

Ibrahim, H., Perl, A., Smith, D. E., Lewis, T. C., Kon, Z. N., Goldenberg, R., Yarta, K., Staniloae, C. S., & Williams, M. R. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108544 · Cited by 151

Thrombotic complications of COVID-19

Avila, J., Long, B., Holladay, D., & Gottlieb, M. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.09.065 · Cited by 143

Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study

Tremblay, D. A., van Gerwen, M. A. G., Alsen, M., Thibaud, S., Kessler, A. J., Venugopal, S., Makki, I., Qin, Q., Dharmapuri, S., Jun, T. W., et al. (2020) · Blood · doi:10.1182/blood.2020006941 · Cited by 143

COVID-19 and the Kidneys: An Update

Benedetti, C., Waldman, M. A., Zaza, G., Riella, L. V., & Cravedi, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00423 · Cited by 145

Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology

Cardoso, E. M., Hundal, J., Jimenez, D. F., & Magaldi, J. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05310-1 · Cited by 156

Ischemic stroke associated with COVID-19: a systematic review and meta-analysis

Luo, W., Liu, X., Bao, K., & Huang, C. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10837-7 · Cited by 153

Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study

Alharthy, A. M., Aletreby, W., Faqihi, F. A., Balhamar, A., Alaklobi, F., Alanezi, K., Jaganathan, P. P., Tamim, H., Alqahtani, S. A., Karakitsos, D., et al. (2020) · Journal of Epidemiology and Global Health · doi:10.2991/jegh.k.200928.001 · Cited by 133

Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic

Herman, A., Peeters, C., Verroken, A., Tromme, I., Tennstedt, D., Marot, L., Dachelet, C., Gruson, D., Hermans, C. R. J. R., & Baeck, M. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.2368 · Cited by 135

Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms

Criado, P. R., Abdalla, B. M. Z., de Assis, I. C., Mello, C. V. B. D. G., Caputo, G. C., & Vieira, I. C. (2020) · Inflammation Research · doi:10.1007/s00011-020-01370-w · Cited by 142

COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations

Ho, D. C. W., Low, R., Tong, L. H. T., Gupta, V., Veeraraghavan, A., & Agrawal, R. V. (2020) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2020.1772313 · Cited by 134

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability

Rico-Mesa, J. S., Rosas, D., Ahmadian-Tehrani, A., White, A., Anderson, A. S., & CHILTON, R. J. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01328-8 · Cited by 134

Cutaneous manifestations of SARS‐CoV‐2 infection: a clinical update

Gisondi, P., Piaserico, S., Bordin, C. R., Alaibac, M., Girolomoni, G., & Naldi, L. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16774 · Cited by 134

COVID‐19 coagulopathy: An in‐depth analysis of the coagulation system

Martín‐Rojas, R. M., Pérez‐Rus, G., Delgado‐Pinos, V. E., Domingo‐González, A., Regalado‐Artamendi, I., Alba‐Urdiales, N., Rodríguez, P. D., Monsalvo, S., Rodríguez‐Macías, G., Ballesteros, M., et al. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13501 · Cited by 135

Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID

Vojdani, A., Vojdani, E., Saidara, E., & Maes, M. H. J. (2023) · Viruses · doi:10.3390/v15020400 · Cited by 138

Disseminated intravascular coagulation and its immune mechanisms

Popescu, N. I., Lupu, C., & Lupu, F. (2021) · Blood · doi:10.1182/blood.2020007208 · Cited by 140

Coagulopathy in COVID-19: Manifestations and management

Mucha, S. R., Dugar, S. P., McCrae, K. R., Joseph, D., Bartholomew, J. R., Sacha, G. L., & Militello, M. A. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc024 · Cited by 130

Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment

Shah, S., Danda, D., Kavadichanda, C. G., Das, S., Adarsh, M. B., & Negi, V. S. (2020) · Rheumatology International · doi:10.1007/s00296-020-04639-9 · Cited by 130

COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking

Magro, G. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198070 · Cited by 131

Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis

Wu, T., Zuo, Z., Kang, S., Jiang, L., Luo, X., Xia, Z., Liu, J., Xiao, X., Ye, M., & Deng, M. (2020) · Aging and Disease · doi:10.14336/ad.2020.0520 · Cited by 126

Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients

Mouhat, B., Besutti, M., Bouiller, K., Grillet, F., Monnin, C., Ecarnot, F., Behr, J., Capellier, G., Soumagne, T., Pili‐Floury, S., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01811-2020 · Cited by 128

Prognostic Assessment of COVID-19 in the Intensive Care Unit by Machine Learning Methods: Model Development and Validation

Pan, P., Li, Y., Xiao, Y., Han, B., Su, L., Su, M., Li, Y., Zhang, S., Jiang, D., Chen, X., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/23128 · Cited by 126

Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19

Naymagon, L., Zubizarreta, N. J., Feld, J., van Gerwen, M. A. G., Alsen, M., Thibaud, S., Kessler, A. J., Venugopal, S., Makki, I., Qin, Q., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.08.032 · Cited by 127

Central Nervous System Manifestations Associated with COVID-19

Divani, A. A., Andalib, S., Biller, J., Napoli, M. D., Moghimi, N., Rubiños, C., Nobleza, C. O., Sylaja, P. N., Toledano, M., Lattanzi, S., et al. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01079-7 · Cited by 129

Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?

Tal, S., Spectre, G., Kornowski, R., & Perl, L. (2020) · Acta Haematologica · doi:10.1159/000508233 · Cited by 126

Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort

Xia, P., Wen, Y., Duan, Y., Su, H., Cao, W., Xiao, M., Ma, J., Zhou, Y., Chen, G., Jiang, W., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040426 · Cited by 126

Skin manifestations of COVID‐19 in children: Part 1

Martínez, D. A., Fortina, A. B., Bodemer, C., Bonifazi, E., Chiriac, A. E., Colmenero, I., Diociaiuti, A., El‐Hachem, M., Fertitta, L., Gysel, D. V., et al. (2020) · Clinical and Experimental Dermatology · doi:10.1111/ced.14481 · Cited by 129

ANTIPHOSPHOLIPID-LIKE SYNDROME INDUCED BY COVID19: A CASE REPORT STUDY

Marinkovic, S. P., Anastasovski, A., & Todorovska, L. (2024) · Journal of Morphological Sciences · doi:10.55302/jms2471171pm

The changes of Coagulation State in Patients Contracted with SARS-COV-19

Nosrati, A. (2020) · Iranian journal of pathology · doi:10.30699/ijp.2020.129354.2427 · Cited by 1

Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

Xiao, M., Zhang, Y., Zhang, S., Qin, X., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41425 · Cited by 174

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Zhang, Y., Cao, W., Jiang, W., Xiao, M., Li, Y., Tang, N., Liu, Z., Yan, X., Zhao, Y., Li, T., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02182-9 · Cited by 162

Evaluation of Antiphospholipid Antibodies in COVID-19 Patients with Coagulopathy.

Nosrati, A., Torabizadeh, Z., Kheirkhah, D., Larijani, L. V., Alizade-Navaei, R., Mobini, M., Aliyali, M., Abedi, S., & Mehravaran, H. (2022) · PubMed Central · Cited by 2